Andreas Strüngmann (born 1950) is a German businessman and founded generic drug maker Hexal AG ($1.6 billion sales during 2004) in 1986. It became Germany's second-largest generic drug producer. In February 2005, he and his brother Thomas sold Hexal and their 67.7% of U.S. Eon Labs to Novartis for $7.5 billion, making Sandoz the largest generic-drug company in the world.
He currently has residences in Tegernsee and South Africa and is married with two children. At age 56, he accepted an executive position at Sandoz, a generics division of Novartis.
|This German business-related biographical article is a stub. You can help Wikipedia by expanding it.|